Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Army
Chubb
Cerilliant
Harvard Business School
McKinsey
Fish and Richardson
Merck
Moodys

Generated: June 25, 2018

DrugPatentWatch Database Preview

TONOCARD Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tonocard, and what generic alternatives are available?

Tonocard is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in TONOCARD is tocainide hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tocainide hydrochloride profile page.
Summary for TONOCARD
Drug patent expirations by year for TONOCARD
Medical Subject Heading (MeSH) Categories for TONOCARD
Synonyms for TONOCARD
(+)-2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride
(1)-2-Amino-N-(2,6-dimethylphenyl)propionamide hydrochloride
2-Amino-2',6'-propionoxylidide hydrochloride
2-Amino-N-(2,6-dimethylphenyl)propanamide hydrochloride
2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride
2-amino-N-(2,6-dimethylphenyl)propanamide;hydrochloride
35891-93-1
41708-72-9 (Parent)
53984-76-2
71395-14-7
AC1L33H5
AC1Q5LWF
ACM35891931
API0008387
CAS-35891-93-1
CCG-213604
CHEMBL1200773
CTK1H0899
D02088
DSSTox_CID_25540
DSSTox_GSID_45540
DSSTox_RID_80942
DTXSID5045540
EINECS 275-361-2
HMS1571M15
LP00344
LS-119013
n-(2,6-dimethylphenyl)alaninamide hydrochloride(1:1)
NCGC00017005-01
NCGC00162129-06
NCGC00261029-01
OR149626
Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, monohydrochloride
Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, monohydrochloride, ( -)-
SCHEMBL122779
Tocainide (+-)-form hydrochloride
Tocainide HCl
Tocainide hydrochloride
Tocainide hydrochloride (USP)
Tocainide hydrochloride, >=98% (HPLC), solid
Tocainide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tocainide Monohydrochloride
Tocainide-hydrochloride
Tocainidehydrochloride
Tonocard (TN)
Tox21_110732
Tox21_110732_1
Tox21_500344
Xylotocan

US Patents and Regulatory Information for TONOCARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for TONOCARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
US Department of Justice
Farmers Insurance
Teva
Cipla
Citi
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.